These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 19388838)

  • 1. Need for both antibiotic cycling and stringent environmental controls to prevent Pseudomonas infections.
    Curtis L
    Surg Infect (Larchmt); 2009 Apr; 10(2):163. PubMed ID: 19388838
    [No Abstract]   [Full Text] [Related]  

  • 2. Problems with pseudomonas.
    McLellan E; Tomlin K
    J Hosp Infect; 2010 May; 75(1):75-6. PubMed ID: 20227786
    [No Abstract]   [Full Text] [Related]  

  • 3. [Attention-getting cross infections: Multidrug resistant Pseudomonas aeruginosa infections].
    Asano K
    Nihon Naika Gakkai Zasshi; 2007 Nov; 96(11):2465-9. PubMed ID: 18069299
    [No Abstract]   [Full Text] [Related]  

  • 4. Usefulness of a computerized expert system associated with systematic O-serotyping for the early detection of outbreaks of hospital acquired infections and for the presumptive antibiotic therapy of Pseudomonas aeruginosa infections.
    Watine J; Charet JC; Bruel A; Bouilloux JP; Palliez J
    Pathol Biol (Paris); 1996 Feb; 44(2):125-31. PubMed ID: 8761597
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An outbreak of imipenem-resistant Pseudomonas aeruginosa in an intensive care unit.
    Majumdar S; Kirby A; Berry N; Williams C; Hassan I; Eddleston J; Burnie JP
    J Hosp Infect; 2004 Oct; 58(2):160-1. PubMed ID: 15474190
    [No Abstract]   [Full Text] [Related]  

  • 6. Outbreak of resistant Pseudomonas aeruginosa infections during a quarterly cycling antibiotic regimen.
    Hedrick TL; Schulman AS; McElearney ST; Smith RL; Swenson BR; Evans HL; Truwit JD; Scheld WM; Sawyer RG
    Surg Infect (Larchmt); 2008 Apr; 9(2):139-52. PubMed ID: 18426346
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Role of Pseudomonas aeruginosa in the etiology of infectious complications in cancer patients].
    Smolianskaia AZ; Sakaian NN; Grinenko GI; Anan'ev VS; Dronova OM
    Vopr Onkol; 1986; 32(12):33-7. PubMed ID: 3099468
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Should we be afraid of the Green Monster?
    Rumbaugh K
    Crit Care Med; 2009 May; 37(5):1826-7. PubMed ID: 19373066
    [No Abstract]   [Full Text] [Related]  

  • 9. [Possibilities and prospects of immunoprophylaxis and immunotherapy of pyocyanic infections under supervision of these infections using epidemiological markers].
    Meitert E; Meitert T
    Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol; 1983; 32(4):289-302. PubMed ID: 6320334
    [No Abstract]   [Full Text] [Related]  

  • 10. [Does a rational therapeutic plan exist for nosocomial bacteremia caused by Pseudomonas aeruginosa?].
    Torné J; García Flores A; Tomás S; Serrano R
    Med Clin (Barc); 1987 Oct; 89(13):572. PubMed ID: 3121961
    [No Abstract]   [Full Text] [Related]  

  • 11. Controlling the clonal spread of Pseudomonas aeruginosa infection.
    Pereira GH; Levin AS; Oliveira HB; Moretti ML
    Infect Control Hosp Epidemiol; 2008 Jun; 29(6):549-52. PubMed ID: 18476775
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fluoroquinolone use is not associated with the change in imipenem susceptibility of Pseudomonas aeruginosa in 25 hospitals.
    Eagye KJ; Nicolau DP
    Adv Ther; 2011 Apr; 28(4):326-33. PubMed ID: 21445549
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Control of an outbreak of carbapenem-resistant Pseudomonas aeruginosa in a haemato-oncology unit.
    Nagao M; Iinuma Y; Igawa J; Saito T; Yamashita K; Kondo T; Matsushima A; Takakura S; Takaori-Kondo A; Ichiyama S
    J Hosp Infect; 2011 Sep; 79(1):49-53. PubMed ID: 21722990
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of Pseudomonas aeruginosa infection.
    Eykyn SJ
    Br J Hosp Med; 1984 Feb; 31(2):136-40. PubMed ID: 6421353
    [No Abstract]   [Full Text] [Related]  

  • 15. Investigation of a nosocomial outbreak by alginate-producing pan-antibiotic-resistant Pseudomonas aeruginosa.
    Yakupogullari Y; Otlu B; Dogukan M; Gursoy C; Korkmaz E; Kizirgil A; Ozden M; Durmaz R
    Am J Infect Control; 2008 Dec; 36(10):e13-8. PubMed ID: 19084158
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Management of an epidemic caused by Pseudomonas aeruginosa].
    Cencetti S; Martino G; Venditti M
    Ann Ig; 2000; 12(4 Suppl 2):123-5. PubMed ID: 11100562
    [No Abstract]   [Full Text] [Related]  

  • 17. [In-vitro antibiotic resistance of hospital and non-hospital strains of Pseudomonas aeruginosa].
    Ceddia T; Marinucci MC; Parravano N
    Boll Soc Ital Biol Sper; 1979 Mar; 55(6):529-33. PubMed ID: 121701
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk factors for imipenem-resistant Pseudomonas aeruginosa: a comparative analysis of two case-control studies in hospitalized patients.
    Zavascki AP; Cruz RP; Goldani LZ
    J Hosp Infect; 2005 Feb; 59(2):96-101. PubMed ID: 15620442
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Pseudomonas pyocyanea infections in otorhinolaryngology].
    Nicoucar GR
    Pract Otorhinolaryngol (Basel); 1969; 31(6):359-64. PubMed ID: 4314671
    [No Abstract]   [Full Text] [Related]  

  • 20. Control of Pseudomonas aeruginosa infections.
    Klastersky J
    Acta Clin Belg; 1974; 29(4):233-9. PubMed ID: 4215269
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.